Author Search Results :: Library Catalog

1
$High-density lipoprotein subfractions - What the clinicians need to know$
High-density lipoprotein subfractions - What the clinicians need to know by Pirillo, A., Norata, Giuseppe, Catapano, A.

Published 2013

Get full text
QR Code
2
Postprandial lipemia as a cardiometabolic risk factor by Pirillo, A., Norata, Giuseppe, Catapano, A.

Published 2014

Get full text
QR Code
3
Vascular inflammation and low-density lipoproteins: Is cholesterol the link? A lesson from the clinical trials by Catapano, A., Pirillo, A., Norata, Giuseppe

Published 2017

Get full text
QR Code
4
Therapy and clinical trials: Aggressive statin therapy versus combined and emerging approaches by Catapano, A., Norata, Giuseppe, Pirillo, A.

Published 2011

Get full text
QR Code
5
Niemann-pick C1-like 1 (NPC1L1) inhibition and cardiovascular diseases by Pirillo, A., Catapano, A., Norata, Giuseppe

Published 2016

Get full text
QR Code
6
LOX-1, OxLDL, and atherosclerosis by Pirillo, A., Norata, Giuseppe, Catapano, A.

Published 2013

Get full text
QR Code
7
HDLs, immunity, and atherosclerosis by Norata, Giuseppe, Pirillo, A., Catapano, A.

Published 2011

Get full text
QR Code
8
Treating high density lipoprotein cholesterol (HDL-C): Quantity versus quality by Pirillo, A., Norata, Giuseppe, Catapano, A.

Published 2013

Get full text
QR Code
9
HDL in infectious diseases and sepsis by Pirillo, A., Catapano, A., Norata, Giuseppe

Published 2015

Get full text
QR Code
10
Targeting Cholesterol in Non-ischemic Heart Failure: A Role for LDLR Gene Therapy? by Catapano, A., Pirillo, A., Norata, Giuseppe

Published 2017

Get full text
QR Code
11
Strategies for the use of nonstatin therapies by Pirillo, A., Norata, Giuseppe, Catapano, A.

Published 2017

Get full text
QR Code
12
Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: Patient selection and perspectives by Catapano, A., Pirillo, A., Norata, Giuseppe

Published 2017

Get full text
QR Code
13
Apolipoprotein C-III: From Pathophysiology to Pharmacology by Norata, Giuseppe, Tsimikas, S., Pirillo, A., Catapano, A.

Published 2015

Get full text
QR Code
14
The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis by Pirillo, A., Bonacina, F., Norata, Giuseppe, Catapano, A.

Published 2018

Get full text
QR Code
15
Emerging role of high density lipoproteins as a player in the immune system by Norata, Giuseppe, Pirillo, A., Ammirati, E., Catapano, A.

Published 2012

Get full text
QR Code
16
HDL: To treat or not to treat? by Pirillo, A., Tibolla, G., Norata, Giuseppe, Catapano, A.

Published 2014

Get full text
QR Code
17
HDL in innate and adaptive immunity by Catapano, A., Pirillo, A., Bonacina, F., Norata, Giuseppe

Published 2014

Get full text
QR Code
18
PCSK9 inhibition in statin-intolerant HeFH patients: What's new? by Casula, M., Pirillo, A., Norata, Giuseppe, Catapano, A.

Published 2017

Get full text
QR Code
19
Biology of proprotein convertase subtilisin kexin 9: Beyond low-density lipoprotein cholesterol lowering by Norata, Giuseppe, Tavori, H., Pirillo, A., Fazio, S., Catapano, A.

Published 2016

Get full text
QR Code
20
Effect of treatment with pravastatin or ezetimibe on endothelial function in patients with moderate hypercholesterolemia by Grigore, L., Raselli, S., Garlaschelli, K., Redaelli, L., Norata, Giuseppe, Pirillo, A., Catapano, A.

Published 2013

Get full text
QR Code

Search Results - Pirillo, A.

High-density lipoprotein subfractions - What the clinicians need to know by Pirillo, A., Norata, Giuseppe, Catapano, A.

Postprandial lipemia as a cardiometabolic risk factor by Pirillo, A., Norata, Giuseppe, Catapano, A.

Vascular inflammation and low-density lipoproteins: Is cholesterol the link? A lesson from the clinical trials by Catapano, A., Pirillo, A., Norata, Giuseppe

Therapy and clinical trials: Aggressive statin therapy versus combined and emerging approaches by Catapano, A., Norata, Giuseppe, Pirillo, A.

Niemann-pick C1-like 1 (NPC1L1) inhibition and cardiovascular diseases by Pirillo, A., Catapano, A., Norata, Giuseppe

LOX-1, OxLDL, and atherosclerosis by Pirillo, A., Norata, Giuseppe, Catapano, A.

HDLs, immunity, and atherosclerosis by Norata, Giuseppe, Pirillo, A., Catapano, A.

Treating high density lipoprotein cholesterol (HDL-C): Quantity versus quality by Pirillo, A., Norata, Giuseppe, Catapano, A.

HDL in infectious diseases and sepsis by Pirillo, A., Catapano, A., Norata, Giuseppe

Targeting Cholesterol in Non-ischemic Heart Failure: A Role for LDLR Gene Therapy? by Catapano, A., Pirillo, A., Norata, Giuseppe

Strategies for the use of nonstatin therapies by Pirillo, A., Norata, Giuseppe, Catapano, A.

Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: Patient selection and perspectives by Catapano, A., Pirillo, A., Norata, Giuseppe

Apolipoprotein C-III: From Pathophysiology to Pharmacology by Norata, Giuseppe, Tsimikas, S., Pirillo, A., Catapano, A.

The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis by Pirillo, A., Bonacina, F., Norata, Giuseppe, Catapano, A.

Emerging role of high density lipoproteins as a player in the immune system by Norata, Giuseppe, Pirillo, A., Ammirati, E., Catapano, A.

HDL: To treat or not to treat? by Pirillo, A., Tibolla, G., Norata, Giuseppe, Catapano, A.

HDL in innate and adaptive immunity by Catapano, A., Pirillo, A., Bonacina, F., Norata, Giuseppe

PCSK9 inhibition in statin-intolerant HeFH patients: What's new? by Casula, M., Pirillo, A., Norata, Giuseppe, Catapano, A.

Biology of proprotein convertase subtilisin kexin 9: Beyond low-density lipoprotein cholesterol lowering by Norata, Giuseppe, Tavori, H., Pirillo, A., Fazio, S., Catapano, A.

Effect of treatment with pravastatin or ezetimibe on endothelial function in patients with moderate hypercholesterolemia by Grigore, L., Raselli, S., Garlaschelli, K., Redaelli, L., Norata, Giuseppe, Pirillo, A., Catapano, A.

Search Tools: